Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.65 |
| ▸ | OPRL1 | P41146 | 9/20 | 0.59 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.58 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Neuropeptide S SCHEMBL29464558 | 0.95 | TFPI (0.61) | TFPIOPRL1VIPR1 | |
| SCHEMBL31060486 | 0.92 | OPRL1 (0.69) | TFPIOPRL1 | |
| SCHEMBL31593267 | 0.91 | IL23R (0.59) | TFPIOPRL1 | |
| SCHEMBL31005075 | 0.90 | TFPI (0.66) | TFPIVIPR1VIPR2 | |
| SCHEMBL30974343 | 0.90 | TFPI (0.58) | TFPIOPRL1VIPR1VIPR2 | |
| SCHEMBL30974318 | 0.90 | TFPI (0.58) | TFPIOPRL1VIPR1VIPR2 | |
| SCHEMBL30880880 | 0.90 | TFPI (0.60) | TFPIOPRL1VIPR1VIPR2 | |
| Nociceptin SCHEMBL29356402 | 0.89 | OPRL1 (0.66) | TFPIOPRL1VIPR1VIPR2 | |
| SCHEMBL29624097 | 0.89 | VIPR1 (0.68) | TFPIVIPR1VIPR2 | |
| SCHEMBL30436216 | 0.89 | TFPI (0.79) | TFPIVIPR1VIPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250340892-A1 | GRAM-NEGATIVE BACTERIA CONTAINING PEPTIDE SECRETION SYSTEM | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250340892-A1 | GRAM-NEGATIVE BACTERIA CONTAINING PEPTIDE SECRETION SYSTEM | PSAT1, CAB39, MRPL21 | TFPI 1582/4885OPRL1 3081/4885VIPR1 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.